 |
The business
Performance 2001*
| Sales |
Operating profit |
R&D expenditure |
Employees |
| £681 million, |
£72 million, |
£86 million, |
4,400 |
| up 12% |
up 6% |
up 22% |
|
*All results are stated before exceptional items
and goodwill amortisation and in UK GAAP. Growth rates are at constant
exchange.
Product portfolio
From genes to drugs
For market information, see Biosciences
Market Report.
|
|
